2013 American Transplant Congress
Public Awareness and Attitudes to Living Organ Donation
Background: The deceased donor organ shortage has driven widespread adoption of living donor transplantation. Yet, public preferences for living donation are not well understood. This…2013 American Transplant Congress
Limits of Paired Donation – Who Doesn’t Get Transplanted?, The
Introduction: Kidney paired donation (KPD) aims to provide compatible donors for ABO incompatible (ABOi) or +XM candidates. However, donors with rare HLA types or blood…2013 American Transplant Congress
Early Complications after ABO Incompatible Kidney Transplantation: A National Database Study
Saint Louis Univ; Dartmouth Univ; Johns Hopkins Univ, ; Washington Univ
ABO incompatible (ABOi) live donor kidney transplantation (LKDT) with plasmapheresis can achieve acceptable graft survival. However, intermediate outcomes after ABOi LDKT have not been described…2013 American Transplant Congress
Family Experiences and Perspectives on Deceased Organ and Tissue Donation for Transplantation
Background: A contributing factor to the shortage of deceased organ donors is family refusal to give consent, or veto a prior decision of the donor.…2013 American Transplant Congress
Comparison of Transumbilical and Conventional Laparoscopic Donor Nephrectomy
Forty-eight healthy voluntary renal donors between 18 and 60 years of age with BMI less than 30 who were planned for laparoscopic left side donor…2013 American Transplant Congress
Liver Transplantation: Do Senescence and Autophagy Modulate the Development of Chronic Pathology
During the past 20 years there has been a reduction in the incidence of both acute cellular rejection (ACR) and chronic ductopenic rejection following liver…2013 American Transplant Congress
Efficacy of Everolimus with Reduced Cyclosporine in Japanese De Novo Renal Transplant Recipients: 24-Month, Randomized, Multicenter Study
Introduction: Results from study A1202 showed that everolimus (EVR) plus reduced dose cyclosporine (rCsA) prevents acute rejection, preserves renal function, and reduces incidence of viral…2013 American Transplant Congress
Positive Flow Crossmatches in Renal Patients without “Detectable” Anti-Donor HLA Antibodies; Maximizing Renal Transplant Rate by Decreasing False Positive Crossmatches
HLA Laboratory and the Transplant Center, Lehigh Valley Health Network, Allentown, PA
A recurring problem in recipient selection for deceased donor renal transplantation is a positive crossmatch in a “non-donor antigen sensitized “individuals. We initiated a study…2013 American Transplant Congress
IL-33: Friend or Foe?
Introduction We hypothesize that innate inflammatory response either preexistent in the recipient or released by injured allografts during transplantation may influence graft outcome. In a…2013 American Transplant Congress
Effects of Everolimus and Tacrolimus Exposure on Efficacy and Renal Function in Liver Transplant Recipients at 24 Months in a Randomized Trial (H2304)
For the H2304 Study Group, Hamburg, Germany; Novartis Pharma AG, Basel, Switzerland
Purpose: The present analysis aims to explore the effect of everolimus (EVR) and tacrolimus (TAC) exposure on efficacy and safety events of interest in de…
American Transplant Congress abstracts